A recent review published in JAMA found that the evidence to support the use of cannabis and cannabinoids for most medical ...

Marijuana may soon be rescheduled, and the biggest change could be taxes. Here’s how reclassification could lower tax bills ...

New research reveals significant gaps between public perception and scientific evidence for medical cannabis benefits across ...

Cannabis industry experts are warning that the benefits from the proposed federal rescheduling of the drug could still be ...

President Trump signed an executive order reclassifying the federal status of marijuana, categorizing it as a drug with less ...

The review also found that daily use of medical cannabis — especially inhaled or high-potency products — may increase the ...

President Donald Trump on Thursday ordered federal agencies to quickly ease restrictions on marijuana and make CBD more available, the latest indicator of how the once-taboo drugs have increasingly ...

President Donald Trump took a major step this week toward reshaping federal drug policy by signing an executive order ...

President Donald Trump’s marijuana rescheduling executive order represents progress, bipartisan lawmakers say. But with that ...

Cannabis moves from Schedule I to Schedule III under the executive order. The president said it 'doesn't legalize marijuana ...

Trump signed an EO to reschedule cannabis, lifting 280E taxes for US MSOs like Cresco Labs, as shares fell on profit taking.

Local dispensary owners say the proposed reclassification offers long-awaited validation, but brings uncertainty about future ...